Search research articles
Contact Us
Filters
Showing results (421-430 of 459) with videos related to
Page
of 46
Sort By:
NPJ Digital Medicine
|
May 3, 2025
Multimodal GPT model for assisting thyroid nodule diagnosis and management
Jincao Yao, Yunpeng Wang, Zhikai Lei, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
January 24, 2022
<i>CD274</i> (<i>PD-L1</i>) Copy Number Changes (Gain) & Response to Immune Checkpoint Blockade Therapy in Carcinomas of the Urinary Tract
Sounak Gupta, Chad M Vanderbilt, Yanming Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 28, 2021
Initial Whole-Genome Sequencing of Plasma Cell Neoplasms in First Responders and Recovery Workers Exposed to the World Trade Center Attack of September 11, 2001
Francesco Maura, Benjamin Diamond, Kylee H Maclachlan, et al.
Blood Neoplasia
|
March 27, 2026
Survival after intensive therapy or clofarabine in fit older adults with acute myeloid leukemia: E2906 phase 3 trial
James M Foran, Zhuoxin Sun, Selina M Luger, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 19, 2019
JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management
Sounak Gupta, John C Cheville, Achim A Jungbluth, et al.
Nature Communications
|
March 26, 2021
Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities
Bénedith Oben, Guy Froyen, Kylee H Maclachlan, et al.
Acta Neuropathologica
|
May 17, 2024
Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors
Andrew L Lin, Vasilisa A Rudneva, Allison L Richards, et al.
Blood
|
May 10, 2024
The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma
Anthony M Cirrincione, Alexandra M Poos, Bachisio Ziccheddu, et al.
Blood Advances
|
February 17, 2026
IMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for NDMM
Kylee H Maclachlan, Carlyn Rose Tan, Tala Shekarkhand, et al.
Blood Cancer Discovery
|
January 4, 2021
Revealing the impact of structural variants in multiple myeloma
Even H Rustad, Venkata D Yellapantula, Dominik Glodzik, et al.
Page
of 46
Search research articles
Search
Showing results (421-430 of 459) with videos related to
Sort By:
Page
of 46
NPJ Digital Medicine
|
May 3, 2025
Multimodal GPT model for assisting thyroid nodule diagnosis and management
Jincao Yao, Yunpeng Wang, Zhikai Lei, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
January 24, 2022
<i>CD274</i> (<i>PD-L1</i>) Copy Number Changes (Gain) & Response to Immune Checkpoint Blockade Therapy in Carcinomas of the Urinary Tract
Sounak Gupta, Chad M Vanderbilt, Yanming Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 28, 2021
Initial Whole-Genome Sequencing of Plasma Cell Neoplasms in First Responders and Recovery Workers Exposed to the World Trade Center Attack of September 11, 2001
Francesco Maura, Benjamin Diamond, Kylee H Maclachlan, et al.
Blood Neoplasia
|
March 27, 2026
Survival after intensive therapy or clofarabine in fit older adults with acute myeloid leukemia: E2906 phase 3 trial
James M Foran, Zhuoxin Sun, Selina M Luger, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 19, 2019
JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management
Sounak Gupta, John C Cheville, Achim A Jungbluth, et al.
Nature Communications
|
March 26, 2021
Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities
Bénedith Oben, Guy Froyen, Kylee H Maclachlan, et al.
Acta Neuropathologica
|
May 17, 2024
Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors
Andrew L Lin, Vasilisa A Rudneva, Allison L Richards, et al.
Blood
|
May 10, 2024
The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma
Anthony M Cirrincione, Alexandra M Poos, Bachisio Ziccheddu, et al.
Blood Advances
|
February 17, 2026
IMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for NDMM
Kylee H Maclachlan, Carlyn Rose Tan, Tala Shekarkhand, et al.
Blood Cancer Discovery
|
January 4, 2021
Revealing the impact of structural variants in multiple myeloma
Even H Rustad, Venkata D Yellapantula, Dominik Glodzik, et al.
Page
of 46